Using current estimates of US long-COVID burden (assuming the probability of long COVID is 6% and symptoms last 1 year), cases cost an average of $2.01 billion annually. The economic burden of long ...

MIT and Caltech scientists designed a new vaccine targeting stable virus regions to protect against various coronavirus strains.

Two-thirds of people with post-COVID-19 syndrome have persistent, objective symptoms—including reduced physical exercise capacity and reduced cognitive test performances—for a year or more, with no ...

Although numerous studies have shown men have more severe acute COVID cases and higher mortality than women, females in their 40s have up to a 45% higher risk of getting long COVID than men, according ...

A new experimental vaccine developed by researchers at MIT and Caltech could offer protection against emerging variants of SARS-CoV-2, as well as related coronaviruses, known as sarbecoviruses, that ...

Roche has obtained U.S. government green lights allowing its point-of-care testing system to be used to screen for multiple sexually transmitted infections from a single sample. | The company’s cobas ...

A recent study finds that the risk for myalgic encephalomyelitis/chronic fatigue syndrome is increased following COVID-19.

The proof-of-concept demonstrates the power of pairing AI with lab orchestration solutions to automate molecular screening ...

Investigators from Mass General Brigham have found that a method originally designed for cancer detection can also identify ...

Any lingering doubts over the feasibility of rolling out population-based cancer registries in low-income and middle-income ...

Discover how the severity of Pediatric Inflammatory Multisystem Syndrome (PIMS-TS) evolved during successive COVID-19 waves, ...